Research Suggests Some Premature Infants May Go Home From the NICU Up To Three Weeks Earlier When Fed Prolacta’s 100% Human Milk-Based Nutritional Products; Those with Bronchopulmonary Dysplasia May Benefit the Most
July 30, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- A retrospective study indicates that premature infants’ stays in neonatal intensive care units (NICUs) are reduced anywhere from 4.5 to 22.9 days...
Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers
July 14, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of an...
Preterm Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers Achieved Catch-Up Growth by Age 2 with Appropriate Neurodevelopmental Outcomes, Study Says
June 01, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a...
Head-to-Head Subgroup Analysis of Human Milk–Based Fortifiers Finds Significant Improvements in Health and Brain Growth Measure for Preemies Fed Mother’s Milk Plus Prolacta’s Fortifiers
May 12, 2020 09:05 ET
|
Prolacta Bioscience
DUARTE, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk–based nutritional products, announced today that a subgroup analysis...
UPDATE - Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
April 02, 2020 23:55 ET
|
Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience,® the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
April 02, 2020 15:50 ET
|
Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Therapeutic Respiratory Devices Market worth over $21.5 billion by 2024: Global Market Insights, Inc.
June 28, 2018 06:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, June 28, 2018 (GLOBE NEWSWIRE) -- Global Therapeutic Respiratory Devices Market is poised to exceed USD 21.5 billion by 2024; according to a new research report by Global...
Innara Health Announces Co-Marketing Agreement with GE Healthcare to Advance Oral Feeding and Neurodevelopment of Premature Infants
March 21, 2017 08:09 ET
|
Innara Health
Olathe, March 21, 2017 (GLOBE NEWSWIRE) -- Contact Wendy SlateryFOR IMMEDIATE RELEASETelephone 608-213-1449 E-mail wslatery@innarahealth.com Innara Health Announces Co-Marketing Agreement with...
NTrainer System® Shown to Help Neonatal Feeding Readiness Skills
March 01, 2016 09:35 ET
|
Innara Health
OLATHE, Kan., March 01, 2016 (GLOBE NEWSWIRE) -- Innara Health today announced that a multi-center randomized control trial (RCT) has shown that premature infants who received treatment with the...
Connecticut Children's Medical Center Hires New Neonatal Intensive Care Unit Chief
February 06, 2015 11:59 ET
|
Connecticut Childrens Medical Center
HARTFORD, Conn., Feb. 6, 2015 (GLOBE NEWSWIRE) -- Connecticut Children's Medical Center is pleased to announce the appointment of James E. Moore. M.D., Ph.D., to Chief of the Neonatal Intensive Care...